NeuroBo Pharmaceuticals (NRBO)
(Delayed Data from NSDQ)
$4.03 USD
+0.07 (1.77%)
Updated May 13, 2024 03:22 PM ET
After-Market: $3.91 -0.12 (-2.98%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.95 | 0.00% |
Earnings Summary
For their last quarter, NeuroBo Pharmaceuticals (NRBO) reported earnings of -$1.32 per share, missing the Zacks Consensus Estimate of -$0.95 per share. This reflects a negative earnings surprise of 38.95%. Look out for NRBO's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.95 per share, reflecting a year-over-year decrease of 493.75%.
Earnings History
Price & Consensus
Zacks News for NRBO
4 Undervalued Medical Stocks to Buy Amid High Market Volatility
NRBO: What are Zacks experts saying now?
Zacks Private Portfolio Services